subscribeSubscribe
ViiV Healthcare announces FDA Approval of Dovato for Adolescents Living with HIV

ViiV Healthcare announces FDA Approval of Dovato for Adolescents Living with HIV
BUSINESSWIRE
08 Apr 2024
Share Share
ViiV Health announces new packaging option now available in the U.S. for Dovato

ViiV Health announces new packaging option now available in the U.S. for Dovato
BUSINESSWIRE
05 Feb 2024
Share Share
Colombia to seek compulsory license on ViiV`s dolutegravir

Colombia to seek compulsory license on ViiV`s dolutegravir
Fraiser Kansteiner FIERCE PHARMA
05 Oct 2023
Share Share
GSK`s ViiV to lean on HIV portfolio ahead of dolutegravir patent expiration

GSK`s ViiV to lean on HIV portfolio ahead of dolutegravir patent expiration
Nicole DeFeudis ENDPTS
28 Sep 2023
Share Share
Viatris Announces U.S. FDA Approval of a Paediatric Formulation of Abacavir

Viatris Announces U.S. FDA Approval of a Paediatric Formulation of Abacavir
PR NEWSWIRE
05 Sep 2023
Share Share
ViiV Healthcare`s Dovato (dolutegravir, lamivudine) Receives Approval in Europe

ViiV Healthcare`s Dovato (dolutegravir, lamivudine) Receives Approval in Europe
EMA
08 Aug 2023
Share Share
Lupin gets FDA tentative approval for dolutegravir tablets for oral suspension

Lupin gets FDA tentative approval for dolutegravir tablets for oral suspension
PHARMABIZ
04 Jul 2023
Share Share
Lupin`s Generic Dolutegravir Sodium Receives Approval in the U.S.

Lupin`s Generic Dolutegravir Sodium Receives Approval in the U.S.
FDA
03 Jul 2023
Share Share
FDA Confirms Paragraph IV Patent Litigation for Abacavir Sulfate, Dolutegravir and Lamivudine Tablets

FDA Confirms Paragraph IV Patent Litigation for Abacavir Sulfate, Dolutegravir and Lamivudine Tablets

FDA
15 Jun 2023
Share Share
Lupin gets USFDA nod for Dolutegravir, Emtricitabine and Tenofovir tablets

Lupin gets USFDA nod for Dolutegravir, Emtricitabine and Tenofovir tablets
ECONOMIC TIMES
31 Jan 2023
Share Share